Sana biotechnology announces several preclinical data presentations at the 64th american society of hematology annual meeting

Seattle, nov. 03, 2022 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that six abstracts have been accepted for presentation, including two oral presentations, at the 64th american society of hematology (ash) annual meeting to be held december 10-13, 2022 in new orleans, la.
SANA Ratings Summary
SANA Quant Ranking